CLYM Climb Bio, Inc.
Price Chart
Executive Summary
Climb Bio, Inc. filed a definitive proxy statement (DEFA14A) for its 2026 annual meeting, proposing the election of two directors, ratification of auditors, and amendments to its charter and equity plan. This is a routine filing with no material changes or activist involvement.
Actionable Insight
Monitor for any shareholder dissent on the equity plan amendment, but expect smooth passage of all proposals given management's unanimous recommendation.
Key Facts
- Proposes election of two Class II directors: Alexander (Bo) Cumbo and Douglas Williams, Ph.D.
- Seeks ratification of PricewaterhouseCoopers LLP as independent auditor.
- Proposes amendment to remove directors for cause and to modify equity plan share pool calculation.
- Follows recent executive departure of CFO's principal accounting officer, but no board shake-up or activist pressure is indicated.
Financial Impact
No immediate financial impact; routine corporate governance matters.
Risk Factors
- Potential shareholder concern over equity plan changes increasing dilution.
- Governance risk if director nominees face unexpected opposition.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-177302 |
| Document: 0001193125-26-177302-index-headers.html | 0001193125-26-177302 |
| Document: 0001193125-26-177302-index.html | 0001193125-26-177302 |
| Document: 0001193125-26-177302.txt | 0001193125-26-177302 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
2d ago
|
8-K
| $11.44 awaiting T+5 | awaiting T+5 | — | $11.44 (+0.00%) |
|
Jun 12, 2026
2d ago
|
424B5
| $11.44 awaiting T+5 | awaiting T+5 | — | $11.44 (+0.00%) |
|
Jun 10, 2026
5d ago
|
EFFECT
| $11.14 awaiting T+5 | awaiting T+5 | — | $11.44 (+2.69%) |
|
Jun 5, 2026
9d ago
|
8-K
| $10.77 awaiting T+5 | awaiting T+5 | — | $11.44 (+6.22%) |
|
May 29, 2026
16d ago
|
S-3
| $11.80 $10.55 | ▼ −10.59% | ▼ −7.84% | $11.44 (−3.05%) |
|
May 7, 2026
5w ago
|
8-K
| $11.91 $11.41 | ▼ −4.20% | ▼ −5.70% | $11.44 (−3.95%) |
|
May 5, 2026
5w ago
|
8-K
| $11.45 $11.17 | ▼ −2.45% | ▼ −4.43% | $11.44 (−0.09%) |
|
Apr 28, 2026
6w ago
|
8-K
| $9.26 $9.69 | ▼ −4.64% | ▼ −2.95% | $11.44 (−23.54%) |
|
Apr 24, 2026
7w ago
|
DEFA14A
| $9.50 $9.69 | ▲ +2.00% | ▲ +1.60% | $11.44 (+20.42%) |
|
Apr 3, 2026
10w ago
|
8-K
| $6.74 $8.63 | ▲ +28.04% | ▲ +23.91% | $11.44 (+69.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access